Q&A with Venture Life CFO Danny Wells
Following yesterday’s positive and in line FY’25 trading update, CFO Danny Wells of Venture Life - a leading consumer healthcare products firm - kindly takes me through the:
00:00 Key drivers underpinning the double digit top line growth
05:10 Health & Her/Him brand
07:15 Performance overseas & expansion into US
11:10 outlook for (17 months ending) May’26 & utilisation of £34.3m cash mountain
16:45 Closing remarks
Disclosure: Venture Life is a Vox Markets client
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
